Search results
Results from the Tech24 Deals Content Network
No, it won't help you take down giants or snow trolls more easily, but a new Skyrim patch does purport to increase the game's performance with certain configurations. Bethesda forum user Arisu has ...
The Elder Scrolls V: Skyrim – Dawnguard is a downloadable content add-on for the action role-playing open world video game The Elder Scrolls V: Skyrim. It was developed by Bethesda Game Studios and published by Bethesda Softworks. The Xbox 360 version of Dawnguard was launched in English-speaking territories on June 26, 2012, and in France ...
Mode (s) Single-player. The Elder Scrolls V: Skyrim – Hearthfire is the second downloadable content add-on for the action role-playing open world video game The Elder Scrolls V: Skyrim. The game was developed by Bethesda Game Studios and published by Bethesda Softworks. The Xbox 360 version of Hearthfire launched on September 4, 2012.
A batch file is a script file in DOS, OS/2 and Microsoft Windows. It consists of a series of commands to be executed by the command-line interpreter, stored in a plain text file. A batch file may contain any command the interpreter accepts interactively and use constructs that enable conditional branching and looping within the batch file, such ...
The full Engadget page consistently loaded a few seconds faster on Froyo, as did any other page we tried. That dovetails nicely with Google's claim that Android 2.2 features the fastest mobile ...
InstallShield. InstallShield is a proprietary software tool for creating installers or software packages. InstallShield is primarily used for installing software for Microsoft Windows desktop and server platforms, though it can also be used to manage software applications and packages on a variety of handheld and mobile devices .
Cherlynn Low / Engadget. Amazon is adding new features to the Kindle Scribe. A new update gives the e-reader / digital notebook new brush types, including a fountain pen, marker and pencil ...
The FDA's approval is based on data from a late-stage trial, which showed that 36.2% of patients treated with Lymphir showed partial or complete response to US FDA approves Citius' blood cancer ...